NIACINAMIDE 4% / TAZAROTENE 0.05% cream

Land: Verenigde Staten

Taal: Engels

Bron: NLM (National Library of Medicine)

Werkstoffen:

NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4), TAZAROTENE (UNII: 81BDR9Y8PS) (TAZAROTENE - UNII:81BDR9Y8PS)

Beschikbaar vanaf:

Sincerus Florida, LLC

Toedieningsweg:

TOPICAL

Prescription-type:

PRESCRIPTION DRUG

Autorisatie-status:

unapproved drug other

Productkenmerken

NIACINAMIDE 4% / TAZAROTENE 0.05%- NIACINAMIDE 4% / TAZAROTENE 0.05%
CREAM
SINCERUS FLORIDA, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
NIACINAMIDE 4% / TAZAROTENE 0.05%
DIRECTIONS FOR USE
SINCERUS FLORIDA, LLC ADVERSE REACTIONS.
ACTIVE, INACTIVE
NDC 72934-2060-2
NIACINAMIDE 4 / TAZAROTENE 0.05
CREAM 30GM
NIACINAMIDE 4% / TAZAROTENE 0.05%
niacinamide 4 % / tazarotene 0.05% cream
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:729 34-216 0
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
NIACINAMIDE (UNII: 25X51I8 RD4) (NIACINAMIDE - UNII:25X51I8 RD4)
NIACINAMIDE
4 g in 10 0 g
TAZARO TENE (UNII: 8 1BDR9 Y8 PS) (TAZAROTENE - UNII:8 1BDR9 Y8 PS)
TAZAROTENE
0 .0 5 g in 10 0 g
Sincerus Florida, LLC
PRODUCT CHARACTERISTICS
COLOR
white
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:729 34-216 0 -
2
30 g in 1 BOTTLE, PUMP; Type 0 : No t a Co mbinatio n
Pro duc t
0 5/0 1/20 19
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 5/0 1/20 19
LABELER -
Sincerus Florida, LLC (080105003)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Sincerus Flo rida, LLC
0 8 0 10 50 0 3
ma nufa c ture (729 34-216 0 )
Revised: 4/2019